Novabay Pharmaceuticals (NBY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,309 | 5,344 | 8,467 | 430 | 776 |
| Receivables | 368 | N/A | N/A | N/A | 704 |
| Inventories | N/A | 467 | N/A | N/A | 473 |
| Other current assets | 0 | 0 | 0 | 1,233 | 0 |
| TOTAL | $2,898 | $6,115 | $9,038 | $1,935 | $2,279 |
| Non-Current Assets | |||||
| PPE Net | 6 | 11 | 12 | 44 | 61 |
| Other Non-Current Assets | 583 | 785 | 822 | 1,444 | 1,537 |
| TOTAL | $589 | $796 | $834 | $1,488 | $1,598 |
| Total Assets | $3,487 | $6,911 | $9,872 | $3,423 | $3,877 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 500 | N/A |
| Accounts payable and accrued liabilities | 76 | 604 | 800 | 109 | 396 |
| Accrued Expenses | 807 | 1,020 | 1,780 | 581 | 1,147 |
| TOTAL | $1,448 | $2,144 | $3,067 | $2,843 | $1,984 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 405 | 522 | 638 | 709 | 821 |
| TOTAL | $405 | $522 | $638 | $709 | $821 |
| Total Liabilities | $1,853 | $2,666 | $3,705 | $3,552 | $2,805 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 126,011 | 5,823 | 5,816 | 5,816 | 4,886 |
| Common Shares | 60 | 58 | 58 | 49 | 49 |
| Retained earnings | -183,817 | -177,709 | -175,787 | -183,457 | -182,245 |
| Other shareholders' equity | 3,792 | 0 | 0 | 6 | 6 |
| TOTAL | $1,634 | $4,245 | $6,167 | $-129 | $1,072 |
| Total Liabilities And Equity | $3,487 | $6,911 | $9,872 | $3,423 | $3,877 |